// App-Quantinova.ai

: Patients with Primary CNS Lymphoma Have High Rates of Venous Thromboembolism during R‐MPV Chemotherapy

Researchers

Presenter

  • H.L.A. Yuen

Principal Investigators

  • A. Slocombe

  • V. Heron

  • S. Chunilal

  • J. Shortt

  • M. Tartarczuch

  • G. Grigoriadis

  • S. Patil

  • G. Gregory

  • S. Opat

  • M. Gilbertson

Medical Centers

  • Monash Health, Monash Haematology, Clayton, Australia

  • Deakin University, Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Primary central nervous system lymphoma

  • CNS lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • procarbazine

  • Vincristine

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved